The newly discovered variant enhancer loci: providing new epigenetic clues for biomarker discovery in colon cancer?

Author： Moreira Leticia Balaguer Francesc

ISSN： 1741-0541

Source： Personalized Medicine, Vol.9, Iss.7, 2012-09, pp. : 671-673

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarker discovery in ovarian cancer

By Tung Celestine S Wong Kwong-Kwok Mok Samuel C

Women's Health, Vol. 4, Iss. 1, 2008-01 ,pp. : 27-40

Future Medicine

Access to resources Recommend Favorite

Irisin, a newly discovered myokine, is a novel biomarker associated with physical activity in patients with chronic obstructive pulmonary disease

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 4, 2015-05 ,pp. : 612-617

John Wiley & Sons Inc

Access to resources Recommend Favorite

Discovery of a novel epigenetic cancer marker related to the oxidative status of human blood

GENES, CHROMOSOMES AND CANCER, Vol. 54, Iss. 9, 2015-09 ,pp. : 583-594

John Wiley & Sons Inc

Access to resources Recommend Favorite

Mass spectrometry-based tissue proteomics for cancer biomarker discovery

By Balgley Brian M Wang Weijie De Voe Don L Lee Cheng S

Personalized Medicine, Vol. 4, Iss. 1, 2007-02 ,pp. : 45-58

Future Medicine

Access to resources Recommend Favorite

Early Detection of Colon Cancer: New Tests on the Horizon

By Gupta Akshay K.

Molecular Diagnosis & Therapy, Vol. 12, Iss. 2, 2008-01 ,pp. : 77-85

Adis International

Access to resources Recommend Favorite